Due to the long duration of diabetes, T2D patients have higher risks of macrovascular and microvascular damage, as well as other severe complications, such as diabetic nephropathy, diabetic cardiomyopathy, non-alcoholic fatty liver disease (NAFLD), diabetic retinopathy, cognitive impairment, that cause mortality (Gregg et al., 2014)
What the Research Shows on GLP-1s and Alcohol A study published in The New England Journal of Medicine in April 2025 examined semaglutides impact on alcohol consumption in a small group of participants
Moreover, butyrate treatment improved intestinal barrier function by modulating TJ protein mRNA expression levels (Supplementary Fig
Studies of healed tissue after combination treatment show better outcomes than either peptide alone: improved tensile strength (3040% stronger), better elasticity, less scar tissue (4050% less fibrosis), and superior functional recovery
If you want to make your progress measurable, book a scan and use the data to adjust nutrition and training: Schedule your BodySpec DEXA scan
Semaglutide works with one signal, making it a single agonist, specifically a GLP-1 receptor agonist (Glucagon-Like Peptide-1)
